Effect of Rifaximin on Intestinal Bacterial Overgrowth in Crohn's Disease as Assessed by the H₂-Glucose Breath Test

References

• Aluwihare, A. P. R. (1971). Electron microscopy in Crohn's disease. Gut, 12, 509–518.
   PubMed Web of Science ®Google Scholar
• Beeken, W. L. and Kanich, R. E. (1973). Microbial flora of the upper small bowel in Crohn's disease. Gastroenterology, 65, 390–397.
   PubMed Web of Science ®Google Scholar
• Bernstein, L. H., Frank, M. S., Brandt, L. J. and Boley, S. J. (1980). Healing of perianal Crohn's disease with metronidazole. Gastroenterology, 795, 357–365.
   Google Scholar
• Best, W. R., Becktel, J. M., Singleton, J. W. and Keen, F. (1976). Development of a Crohn's disease activity index. Gastroenterology, 70, 785–787.
   Google Scholar
• Burman, J. H., Thompson, H., Cooke, W. T. and Williams, J. A. (1979). The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut, 11–15.
   Google Scholar
• Chadwick, V. S. and Anderson, R. P. (1992). Microorganisms and their products in inflammatory bowel disease. In: McDermott, R. P. and Stimpson, W. E (Eds), Inflammatory Bowel Disease, Elsevier, New York, 241–258.
   Google Scholar
• Chadwick, V. S. (1992). Immunology of inflammatory bowel disase. Curr. Opin. Gastroenterol., 8, 634–640.
   Web of Science ®Google Scholar
• Corazza, G. R., Menozzi, M. G., Strocchi, A., Rasciti, L., Vaira, D., Lecchini, R., Avanzini, P., Chezzi, C. and Gasbarrini, G. (1990). The diagnosis of small bowel bacterial overgrowth. Gastroenterology, 98, 302–305.
   PubMed Web of Science ®Google Scholar
• Corazza, G. R., Menozzi, M. G. and Vaira, D. (1985). A simpler and more rapid approach to the diagnosis of small bowel bacterial overgrowth. Ital. J. Gastroenterol., 17, 182–188.
   Google Scholar
• Corazza, G. R., Sorge, M., Strocchi, A., Benati, G., Di Sario, A., Treggiari, E. A., Brusco, G. and Gasbarrini, G. (1992). Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital. J. Gastroenterol., 24 (Suppl 2), 4–9.
   PubMedGoogle Scholar
• Descombe, J. J., Duburg, D., Picard, N. and Palazzini, E. (1994). Pharmacokinetic study of Rifaximine after oral administration in healthy volunteers. Int. J. Clin. Pharm. Res., 14, 51–56.
   PubMedGoogle Scholar
• Elliot, P., Lennard-Jones, J. E., Burnham, W., White, R. and Stanford, J. L. (1980). Further data on skin testing with mycobacterial antigens in Crohn's disease. Lancet, ii, 483–484.
   Web of Science ®Google Scholar
• Fluorie, B., Turk, J., Lemann, M., Florent, C., Cohman, R. and Rambaud, J. C. (1989). Breath hydrogen in bacterial overgrowth. Gastroenterology, 98, 302–305.
   Google Scholar
• Gilat, T., Ben Hur, H., Gelman-Malachi, E., Terdiman, R. and Peled, Y. (1978). Alterations of the colonic flora and their effect on the hydrogen breath test. Gut, 19, 602–603.
   PubMed Web of Science ®Google Scholar
• Gillis, J. C. and Brogden, R N. (1995). Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs, 49, 467–484.
   PubMed Web of Science ®Google Scholar
• Graham, D. Y., Markesich, D. C. and Yoshimura, H. H. (1987). Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology, 92, 436–442.
   PubMed Web of Science ®Google Scholar
• Hoover, W. W., Gerlach, E. H., Hoban, D. J., Elkiopoulos, G. M., Pfaller, M. A. and Jones, R. N. (1993). Antimicrobial activity and spectrun of rifaximin, a new topical rifamycin derivative. Diag. Micro biol. Infect. Dis., 16, 1 1 1-118.
   Google Scholar
• Katz, K. D., Hollander, D., Vadheim, C. M., McElree, C., Delahunty, T., Dadufalza, V. D., Krugliak, P. and Rotter, J. I. (1989). Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology, 87, 927–931.
   Google Scholar
• Mishina, D., Katsel, P., Brown, S. T., Gilberts, E. C. A. M. and Greenstein, R. J. (1996). On the ethiology of Crohn's disease. Proc. Natl. Acad. Sci., 93, 9816–9820.
   PubMed Web of Science ®Google Scholar
• Morson, B. C. and Dawson, I. M. P. (1977). Gastrointestinal Pathology. Blackwells, Oxford.
   Google Scholar
• Pallone, F., Poirivant, M., Fais, S., Luzza, E, Doldo, P., Monteleone, G. and Aloi, A. (1992). Antibacterial drugs in Crohn's Disease. Ital. J. Gastroenterol., 24 (Suppl 2), 17–18.
   PubMedGoogle Scholar
• Pallone, F., Ricci, E and Iannoni, C. (1973). Quantitative study of the cell density of the lamina propria in the human rectum. Rendic. Gastroenterol., 5, 223–224.
   Google Scholar
• Perman, J. A. (1991). Clinical application of breath hydrogen measurements. Can. J. Physiol. Pharmacol., 69, 111–115.
   PubMed Web of Science ®Google Scholar
• Prantera, C., Kohn, A., Zannoni, E, Spimpolo, N. and Bonfa, M. (1994). Metronidazole plus ciprofloxacin in the treatment of active refractory Crohn's disease: results of an open study. J. Clin. Gastroenterol. 19, 79–88.
   PubMed Web of Science ®Google Scholar
• Prizont, R., Hersh, T. and Floch, M. H. (1970). Jejunal bacterial flora in chronic small bowel disease. Am. J. Clin. Nutr., 23, 1602–1607.
   Google Scholar
• Rutgeerts, P., Geboes, K., Elemans, J. and Vantrappen, G. (1991). Surgical diversion of fecal stream prevents post operative recurrence in Crohn's disease. Lancet, 1, 396–398.
   Google Scholar
• Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Pennincloc, E, Aerts, R. and Kerremans, R. (1995). Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology, 108, 1617–1621.
   Google Scholar
• Sartor, R. B. (1993). Antimicrobial therapy of inflammatory bowel disease: implications for pathogenesis and management. Can. J. Gastroenterol., 7, 132–138.
   Web of Science ®Google Scholar
• Sartor, R. B. (1994). Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology, 106, 533–539.
   PubMed Web of Science ®Google Scholar
• Strocchi, A., Sorge, M., Pranzo, L., Barbieri, M., Corazza, G. R. and Gasbarrini, A. (1988). Intraindividual variability in H2 production capacity. Gastroenterol. Int., 1 (Suppl 1), 593–594.
   Google Scholar
• Ursing, B. and Kamme, G. (1975). Metronidazole for Crohn's disease. Lancet, 1, 775–777.
   PubMed Web of Science ®Google Scholar
• Vince, A., Dyer, N. H., O'Grady, F. W. and Dawson, A. M. (1972). Bacteriological studies in Crohn's disease. J. Med. Microbiol., 5, 219–229.
   PubMed Web of Science ®Google Scholar